HORIZON DISCOVERY GROUP PLC |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| - GBX | -.--% |
|
-.--% | +23.00% |
Presenter SpeechUnknown Attendee (Attendees)Good day, ladies and gentlemen, and welcome to the...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Horizon Discovery Group Ltd, formerly known as Horizon Discovery Group PLC, is a United Kingdom-based life science company. The Company drives the application of gene editing and gene modulation. It offers a portfolio of tools and services to help scientists understand gene function, identify genetic drivers behind human disease, deliver biotherapeutics, cellular and gene therapies for precision medicine as well as develop and validate diagnostic workflows.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| +23.00% | 412M | |
| -4.66% | 86.13B | |
| +1.32% | 39.82B | |
| -19.27% | 30.42B | |
| +57.86% | 25.23B | |
| -16.09% | 15.35B | |
| -9.14% | 11.95B | |
| -17.69% | 11.6B | |
| -43.00% | 11.51B | |
| +5.24% | 8.71B |
- Stock Market
- Equities
- HZD Stock
- News Horizon Discovery Group plc
- Transcript : Horizon Discovery Group plc - Analyst/Investor Day
